NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Why so much hype for one procedure?

Posted By


The New York Times and at least one television network newscast profiled a first-of-its-kind aortic valve implant done through a catheter feeding the device through a vein in the patient’s leg rather than by open heart surgery.

Why such hype? As the Times reports, the operation was the first of “at least 150 that federal regulators will require before considering approval of the technique for widespread use.”

If the trial fails, will the story get this much coverage? Why can’t we wait until there’s some evidence?

And costs? The new valve implants are expected to cost between $10,000 and $12,000, which is double the price of surgically implanted valves.

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.